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Platypnoea-orthodeoxia syndrome due to a patent
foramen oval with marked lipomatous hypertrophy
Syndrome de platypnée-orthodéoxie en rapport avec un foramen ovale
perméable et importante hypertrophie lipomateuse du septum inter-auriculaire
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An 80-year-old man was admitted with severe refractory hypoxaemia following right lung
radiotherapy for pulmonary carcinoma. The hypoxia was enhanced by the upright position
and was associated with cyanosis. Computed tomography and lung scintigraphy did not
identify a pulmonary cause explaining the degree of hypoxaemia. Transthoracic echocar-
diography (TTE) showed mild aortic root dilatation (48mm) and a highly mobile atrial
septum. Contrast-enhanced TTE showed massive and spontaneous right-to-left shunting
through a large patent foramen oval (PFO). Transoesophageal echocardiography dur-
ing PFO closure identiﬁed a markedly thickened septum secundum due to lipomatous
hypertrophy and a very thin and ﬂoppy septum primum (Fig. 1). Right-sided pres-
sures were within the normal range. A 20-mm sizing balloon (NMT Medical, Boston,
MA) engaged inside the tunnel showed an initial waist due to the septum secundum,
but with further advancement no additional waist was identiﬁed suggesting a large
PFO up to 20mm (Fig. 2). A 35-mm Amplatzer® Cribriform occluder was implanted
with excellent shunt resolution and immediate and sustained improvement in gaseous
exchange (Fig. 3).
The Amplatzer Cribriform occluder is usually indicated for multiperforated inter-atrialinterventionnelle
structurelle
septa, but has proven efﬁcacy in the PFO setting. It can be considered in cases such
as this as it covers both septa well, permits overstretching due to the nitinol cons-
truction, and allows stability testing before delivery. The unusual anatomy more closely
resembles a true septal defect and consequently percutaneous closure is challenging
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Figure 1. Atrial septal anatomy. Right panel: thick septum secundum
Figure 2. Patent foramen oval sizing, using a 20-mm NMT balloon. Rig
Left panel: imprint of the septum secundum.
Figure 3. Amplatzer® Cribriform occluder device. Fluoroscopic
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concerning this article.verview of the implanted device overstretched since the distance
etween the two discs is 6mm (usual distance is 3mm). The diam-
ter remained unchanged (35mm).A. Seemann et al.
(16mm). Left panel: highly mobile thin ﬂoppy septum primum.
ht panel: no imprint when the balloon is advanced inside the PFO.
nd the selection of occluder closure device is critical. Our
ase nicely illustrates the effectiveness of this device with
n unusual anatomy, and for this patient, it provided imme-
iate symptom relief, allowing the patient to be discharged
rom hospital without the need for an oxygen supply.
